Adaptimmune Therapeutics plc/ US00653A1079 /
5/21/2024 9:59:08 PM | Chg. -0.01 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
1.08USD | -0.92% | 40,870 Turnover: 44,058.14 |
-Bid Size: - | -Ask Size: - | 1.10 | 1.06 |
GlobeNewswire
3/8/2022
Adaptimmune to Report Q4 and Full Year 2021 Financial Results and Business Updates on Monday, March ...
GlobeNewswire
1/11/2022
Cabaletta Bio Strengthens Executive Leadership Team with Promotions of Gwendolyn Binder, Ph.D. to Pr...
GlobeNewswire
11/15/2021
Instil Bio Reports Third Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire
11/12/2021
Translational Data at SITC 2021 from Adaptimmune’s Phase 1 SURPASS Trial Indicate Adding AKTi to Man...
GlobeNewswire
11/11/2021
Adaptimmune Reports Positive Results from its Pivotal SPEARHEAD-1 Trial in Patients with Synovial Sa...
GlobeNewswire
11/9/2021
Cabaletta Bio Expands Executive Leadership Team with Appointments of Samik Basu, M.D. to Chief Scien...
GlobeNewswire
10/21/2021
Adaptimmune to Report Q3 2021 Financial Results and Business Update on Thursday, November 4, 2021
GlobeNewswire
9/13/2021
Adaptimmune Announces Clinical Responses across Five Solid Tumor Indications with an Overall Respons...
GlobeNewswire
9/7/2021
Adaptimmune Enters into a Strategic Collaboration with Genentech to Research, Develop, and Commercia...
GlobeNewswire
9/5/2021
Adaptimmune Updates Data from its Phase 1 Trial for Liver Cancer at ILCA Showing Clinical Benefit
GlobeNewswire
7/28/2021
Adaptimmune to Report Q2 2021 Financial Results and Business Update on Monday, August 9, 2021
GlobeNewswire
5/19/2021
Two Complete Responses and Response Rate of 41% for People with Synovial Sarcoma Reported at ASCO in...
GlobeNewswire
5/11/2021
First Preclinical Data from Adaptimmune’s Mesothelin HiT Program at ASGCT Demonstrate Antigen-specif...
GlobeNewswire
4/27/2021
Adaptimmune to Present First Preclinical Data from its HLA-independent TCR (HiT) Platform at ASGCT
GlobeNewswire
4/22/2021
Adaptimmune to Report Q1 2021 Financial Results and Business Update on Thursday, May 6, 2021
GlobeNewswire
2/25/2021
Adaptimmune Reports Fourth Quarter / Full Year 2020 Financial Results and Business Update
GlobeNewswire
2/11/2021
Adaptimmune to Report Fourth Quarter/ Full Year 2020 Financial Results and Business Updates on Thurs...